Pre-Market Actions (VVUS, CHK, CNC, PPL) VIVUS, Inc. (NASDAQ:VVUS) shares fell 1.66 to $22.54 in the pre-market hour after the company yesterday announced that the U.S. Food and Drug Administration (FDA) have extended their deadline by three months for review of the company’s Qnexa(R) PDUFA Date Extension, the latest delay to bring a new...

